Table 3.

Comparison of the anti-JCV antibody status between MS patients with and without fingolimod treatment

History of fingolimod treatment	Yes (n = 83)	No (n = 45)	p value
Anti-JCV antibody, positive	59 (71.1%)	27 (60.0%)	0.239
Anti-JCV antibody index	1.40 [0.26–3.18]	0.57 [0.16–2.97]	0.129
Fingolimod treatment at sampling	Yes (n = 64)	No (n = 64)	p value
Anti-JCV antibody, positive	47 (73.4%)	39 (60.9%)	0.187
Anti-JCV antibody index	1.46 [0.34–3.26]	0.64 [0.16–2.61]	0.039

Values indicate the median [IQR] or count (%)

IQR interquartile range, JCV JC virus, MS multiple sclerosis